A team of researchers discovered a genetic mutation in a non-coding region of DNA that changes thyroid regulation, resulting in a rare type of congenital thyroid abnormality.
A recent study headed by the Lieber Institute for Brain Development found that more than 100 genes linked to the risk of schizophrenia appear to induce disease owing to their activity in the placenta rather than the developing brain.
Antisense oligonucleotides (ASOs), specialised molecules that may regulate RNA and affect protein creation, are being injected directly into the cerebrospinal fluid, the region around the brain and spinal cord, as a prospective treatment for a variety of brain illnesses.